A world without Vioxx: To COX-2 or not to COX-2?

Lee S. Simon, MD
Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA

Vibeke Strand, MD
Adjunct Clinical Professor of Medicine, Stanford University School of Medicine, Stanford, CA

Address: Lee S. Simon, MD, Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 4B, Boston, MA; e-mail lsimon@bidmc.harvard.edu

Dr. Simon has indicated that he has been an investigator and consultant for and has received honoraria from GD Searle, Pharmacia, and Pfizer. He serves as a consultant in drug development for TAP Pharmaceuticals, Sanofi Aventis, AlphaRx, Synta Pharmaceuticals, Roche, Millenium, Cypress, Forrest, Pierre Fabre, Omeros, and Pfizer.

Dr. Strand has indicated that she has worked as an independent consultant for Abbott Immunology, Abgenix, Amgen, Biogen Idec, Celltech, Centocor, Enzon, Genelabs, Genentech, Hoffman, Incyte, La Jolla Pharmaceuticals, Millenium, Novartis, Omeros, Organon, Pfizer Research, Sanofi Aventis, Scios, Serono, SKK, and Sumitomo corporations. She has served on advisory boards for Abbott, Abgenix, Amgen, Aventis, Centocor, Lilly, RWJ Pharmaceutical Research Institute, Roche, Novartis, and Pfizer. She serves on the speakers’ bureaus for Abbott, Amgen, Sanofi Aventis, and Pfizer.